A nasal spray flu vaccine for people up to 49 will be available for home use starting in the fall of 2025 after the Food and ...

The spray could be an alternative for people who are averse to getting injections, or otherwise find it difficult or ...

The F.D.A. authorized AstraZeneca’s treatment to be given outside a health care setting, although it will still need a ...

The Food and Drug Administration on Friday approved the first at-home flu vaccine, a nasal spray that consumers with a ...

The FDA approved FluMist for self- or caregiver-administration, making it the first influenza vaccine that does not need to ...

T he first-ever needleless flu vaccine that can be given at home was just approved by the U.S. Food and Drug Administration.

The FDA Friday approved the flu vaccine that can be done at home and does not need to be administered by a health care provider.

FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States ...

· FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider. · FluMist ...

In a first, the US Food and Drug Administration on Friday approved a nasal spray flu vaccine for self-administration.

FluMist is the only flu vaccine administered by nasal spray, not injection. It is licensed for individuals between the ages ...

The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's nasal spray flu vaccine for ...